Question 1

What is the catalog number for FTSJ3 cDNA Clone?

Accepted Answer

The catalog number for FTSJ3 cDNA Clone is MBS1273200.

Question 2

What sizes are available for FTSJ3 cDNA Clone?

Accepted Answer

FTSJ3 cDNA Clone is available in the following size(s): 0.01 mg Plasmid + 0.2 mL Glycerol-Stock, 5x 0.01 mg Plasmid + 5x 0.2 mL Glycerol-Stock.

Question 3

How many pack sizes does FTSJ3 cDNA Clone come in?

Accepted Answer

FTSJ3 cDNA Clone is available in 2 different pack sizes.

Question 4

Is FTSJ3 cDNA Clone in stock?

Accepted Answer

FTSJ3 cDNA Clone is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Does this product need any special customs documentation to be imported to my country?

Accepted Answer

If you’re outside the EU, UK, or USA, you’re responsible for customs clearance and any related taxes or fees. We provide the standard import documents, such as the Commercial Invoice, Packing List, and Airway Bill, in advance, so let us know early if your customs office needs anything additional for this specific product.

Question 6

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

Question 7

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

FTSJ3 cDNA Clone

Product Specifications

Gene Name

NCBI Gene ID

Other Gene Names

Short Name

Other Product Names

NCBI GI Number

NCBI Accession Number

Available Sizes

Frequently Asked Questions

Explore Other Products

D-VLK-AMC [D-Val-Leu-Lys-AMC]

Tissue FFPE Sections, Prostate

Recombinant GCDFP 15 Antibody

Recombinant GCDFP 15 Antibody

Recombinant GCDFP 15 Antibody

FGF2 Human Gene Knockout Kit (CRISPR)